Gene Panel

Global Market Trajectory & Analytics

MCP12156

EXECUTIVE ENGAGEMENTS

POOL

2772
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

499
Interactions with Platform & by Email

PARTICIPANTS

83
Unique # Participated

VALIDATIONS

24
Responses Validated*

COMPANIES

47
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

102

PAGES

179

EDITION

8

PRICE

USD 4950

CODE

MCP12156


COMPETITIVE METRICS

COMPANY

D S N T

% *

Agilent Technologies, Inc.

Center for Human Genetics and Laboratory Diagnostics

Eurofins Scientific SE

F. Hoffmann-La Roche AG

GENEWIZ

Genomnia

GnuBIO, Inc.

Illumina, Inc.

Integrated DNA Technologies, Inc.

Invivoscribe Inc.

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Gene Panel estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$4.8 Billion by 2027, growing at aCAGR of 19% over the period 2020-2027. Test Kits, one of the segments analyzed in the report, is projected to record 19.5% CAGR and reach US$3.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Testing Services segment is readjusted to a revised 17.8% CAGR for the next 7-year period.
The Gene Panel market in the U.S. is estimated at US$422.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$825.2 Million by the year 2027 trailing a CAGR of 18.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17% and 16.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR.

SELECT PLAYERS

Agilent Technologies, Inc.; ArcherDX, Inc.; Eurofins Scientific SE; F. Hoffmann-La Roche AG; GATC Biotech AG; GENEWIZ; Illumina, Inc.; Integrated DNA Technologies (IDT), Inc.; Personalis, Inc.; QIAGEN GmbH; Thermo Fisher Scientific, Inc.

SEGMENTS

» Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Other Applications) » End-Use (Research & Academic Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) » Product & Service (Test Kits, Testing Services)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Gene Panel: A Prelude
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Gene Panel Methods
Gene Panel Analysis and the Exome Analysis
Evaluation of Gene Panel
Cancer Gene Panels
Multi-Gene Panel Testing
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Gene Panel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Gene Panel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Cancer Risk Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Cancer Risk Assessment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Diagnosis of Congenital Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Diagnosis of Congenital Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharmacogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
Active Players in United States
USA Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
USA Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
USA Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
CANADA
Active Players in Canada
Canada Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
Canada Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
Canada Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
JAPAN
Active Players in Japan
Japan Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
Japan Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
Japan Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
CHINA
Active Players in China
China Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
China Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
China Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Gene Panel by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Gene Panel by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
Europe Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
Europe Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
FRANCE
Active Players in France
France Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
France Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
France Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
GERMANY
Active Players in Germany
Germany Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
Germany Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
Germany Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
ITALY
Active Players in Italy
Italy Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
Italy Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
Italy Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
UNITED KINGDOM
Active Players in United Kingdom
UK Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
UK Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
UK Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
REST OF EUROPE
Active Players in Rest of Europe
Rest of Europe Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
ASIA-PACIFIC
Active Players in Asia-Pacific
Asia-Pacific Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
REST OF WORLD
Active Players in Rest of World
Rest of World Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
Rest of World Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
Rest of World Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
Total Companies Profiled: 47

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com